Robert J. van Ginkel

3.3k total citations
78 papers, 2.0k citations indexed

About

Robert J. van Ginkel is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert J. van Ginkel has authored 78 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 31 papers in Oncology and 30 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert J. van Ginkel's work include Sarcoma Diagnosis and Treatment (28 papers), Intraperitoneal and Appendiceal Malignancies (14 papers) and Appendicitis Diagnosis and Management (13 papers). Robert J. van Ginkel is often cited by papers focused on Sarcoma Diagnosis and Treatment (28 papers), Intraperitoneal and Appendiceal Malignancies (14 papers) and Appendicitis Diagnosis and Management (13 papers). Robert J. van Ginkel collaborates with scholars based in Netherlands, United Kingdom and Germany. Robert J. van Ginkel's co-authors include Harald J. Hoekstra, Albert J.H. Suurmeijer, Schelto Kruijff, M. de Vries, Esther Bastiaannet, Lukas B. Been, Elisabeth Pras, Barbara L. van Leeuwen, Wijnand Helfrich and Douwe F. Samplonius and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Robert J. van Ginkel

77 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. van Ginkel Netherlands 29 890 691 683 303 283 78 2.0k
John B. Schofield United Kingdom 21 472 0.5× 508 0.7× 516 0.8× 96 0.3× 151 0.5× 74 1.6k
Elisabetta Pennacchioli Italy 23 1.2k 1.4× 483 0.7× 1.5k 2.1× 91 0.3× 280 1.0× 67 2.6k
Fritz Lin United States 23 530 0.6× 657 1.0× 517 0.8× 57 0.2× 511 1.8× 51 1.9k
Cynthia E. Herzog United States 32 1.0k 1.1× 625 0.9× 1.1k 1.6× 61 0.2× 617 2.2× 91 2.7k
Guy Lindberg United States 28 307 0.3× 807 1.2× 644 0.9× 185 0.6× 322 1.1× 50 1.8k
Yutaka Takazawa Japan 23 346 0.4× 454 0.7× 521 0.8× 58 0.2× 304 1.1× 133 1.9k
Desmond P.J. Barton United Kingdom 28 648 0.7× 1.1k 1.6× 366 0.5× 72 0.2× 233 0.8× 99 2.5k
Matthew P. Holtzman United States 27 904 1.0× 1.6k 2.3× 441 0.6× 931 3.1× 238 0.8× 82 2.7k
Sa A. Wang United States 38 1.2k 1.4× 251 0.4× 354 0.5× 270 0.9× 940 3.3× 280 5.4k
Clarisse Eveno France 26 464 0.5× 1.3k 1.8× 373 0.5× 629 2.1× 143 0.5× 117 1.9k

Countries citing papers authored by Robert J. van Ginkel

Since Specialization
Citations

This map shows the geographic impact of Robert J. van Ginkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. van Ginkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. van Ginkel more than expected).

Fields of papers citing papers by Robert J. van Ginkel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. van Ginkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. van Ginkel. The network helps show where Robert J. van Ginkel may publish in the future.

Co-authorship network of co-authors of Robert J. van Ginkel

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. van Ginkel. A scholar is included among the top collaborators of Robert J. van Ginkel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. van Ginkel. Robert J. van Ginkel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mheen, Perla J. Marang‐van de, Ellen G. Engelhardt, Marta Fiocco, et al.. (2025). Evaluating the effectiveness of a risk prediction model (PERSARC) on improving treatment decisions quality for patients with soft-tissue sarcomas: the VALUE-PERSARC study. BMC Medical Informatics and Decision Making. 25(1). 345–345.
2.
Ginkel, Robert J. van, et al.. (2024). Twenty-five years of experience with patient-reported outcome measures in soft-tissue sarcoma patients: a systematic review. Quality of Life Research. 33(12). 3189–3211. 4 indexed citations
3.
Sande, Michiel A. J. van de, Cornelis Verhoef, Yvonne Schrage, et al.. (2024). Changes in Health-Related Quality of Life following Surgery in Patients with High-Grade Extremity Soft-Tissue Sarcoma: A Prospective Longitudinal Study. Cancers. 16(3). 547–547. 1 indexed citations
4.
Smolle, Maria Anna, Dimosthenis Andreou, Michiel A. J. van de Sande, et al.. (2023). Effect of radiotherapy on local recurrence, distant metastasis and overall survival in 1200 extremity soft tissue sarcoma patients. Retrospective analysis using IPTW-adjusted models. Radiotherapy and Oncology. 189. 109944–109944. 1 indexed citations
5.
6.
Praag, Veroniek M. van, Desirée M. J. Dorleijn, Cornelis Verhoef, et al.. (2021). Multimodality treatment of undifferentiated pleomorphic soft tissue sarcoma of the extremity (eUPS) in the elderly. European Journal of Surgical Oncology. 48(5). 985–993. 4 indexed citations
7.
Steinkamp, Pieter J., Meifang Li, Matthijs D. Linssen, et al.. (2020). Fluorescence-Guided Visualization of Soft-Tissue Sarcomas by Targeting Vascular Endothelial Growth Factor A: A Phase 1 Single-Center Clinical Trial. Journal of Nuclear Medicine. 62(3). 342–347. 38 indexed citations
8.
Tovote, K. Annika, Thera P. Links, Jan L.N. Roodenburg, et al.. (2019). Reasons for low uptake of a psychological intervention offered to cancer survivors with elevated depressive symptoms. Psycho-Oncology. 28(4). 830–838. 15 indexed citations
9.
Wevers, Kevin P., Anneke C. Muller Kobold, Robert J. van Ginkel, et al.. (2019). S‐100B as an extra selection tool for FDG PET/CT scanning in follow‐up of AJCC stage III melanoma patients. Journal of Surgical Oncology. 120(6). 1031–1037. 5 indexed citations
10.
11.
12.
Hoekstra, Harald J., et al.. (2016). Morbidity After Inguinal Lymph Node Dissections: It Is Time for a Change. Annals of Surgical Oncology. 24(2). 330–339. 30 indexed citations
13.
Gooden, Marloes J.M., Valerie R. Wiersma, Douwe F. Samplonius, et al.. (2013). Galectin-9 Activates and Expands Human T-Helper 1 Cells. PLoS ONE. 8(5). e65616–e65616. 49 indexed citations
14.
Been, Lukas B., Albert J.H. Suurmeijer, Philip H. Elsinga, et al.. (2007). 18F-fluorodeoxythymidine PET for evaluating the response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcomas.. PubMed. 48(3). 367–72. 34 indexed citations
15.
Hoekstra, H. J. & Robert J. van Ginkel. (2003). Hyperthermic isolated limb perfusion in the management of extremity sarcoma. Current Opinion in Oncology. 15(4). 300–303. 8 indexed citations
16.
Zwaveling, Jan H., Harald Hoekstra, John K. Maring, et al.. (1997). Renal Function in Cancer Patients Treated with Hyperthermic Isolated Limb Perfusion with Recombinant Tumor Necrosis Factor-α and Melphalan. Nephron. 76(2). 146–152. 11 indexed citations
17.
Ginkel, Robert J. van, et al.. (1997). Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor. Annals of Surgical Oncology. 4(1). 64–69. 51 indexed citations
18.
Ginkel, Robert J. van, Heimen Schraffordt Koops, Elisabeth G.E. de Vries, et al.. (1996). Hyperthermic isolated limb perfusion with cisplatin in four patients with sarcomas of soft tissue and bone. European Journal of Surgical Oncology. 22(5). 528–531. 18 indexed citations
19.
20.
Zwaveling, Jan H., Han Moshage, Robert J. van Ginkel, et al.. (1996). Role of nitric oxide in recombinant tumor necrosis factor-alpha-induced circulatory shock. Critical Care Medicine. 24(11). 1806–1810. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John B. Schofield Breakdown of academic impact, for papers by Elisabetta Pennacchioli Breakdown of academic impact, for papers by Fritz Lin Breakdown of academic impact, for papers by Cynthia E. Herzog Breakdown of academic impact, for papers by Guy Lindberg Breakdown of academic impact, for papers by Yutaka Takazawa Breakdown of academic impact, for papers by Desmond P.J. Barton Breakdown of academic impact, for papers by Matthew P. Holtzman Breakdown of academic impact, for papers by Sa A. Wang Breakdown of academic impact, for papers by Clarisse Eveno
Rankless by CCL
2026